Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism CAMK2A inhibitors(calcium/calmodulin dependent protein kinase II alpha inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC54H58Cl2N10O11 |
InChIKeyRDVVUBKXCBWLMZ-FCBYTFCFSA-N |
CAS Registry- |